The herein reported increase in BMP-2 plasma levels at stage III CKD patients, but not at earlier stages, might reflect the turning point in vascular calcification, taking into consideration that its prevalence approximately doubles from 25% at CKD stage III [37] to 50% at stage V [38]. This evidence concerns the gene BMP2 and chronic kidney disease.